Preclinical testing of drug delivery systems to bone

Advanced Drug Delivery Reviews

Volumn 94, Issue , 2015, Pages 151-164

  van Griensven, Martijn ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Animal model; Bone regeneration; Critical size defect; Large animals; Load bearing; Non union; Rat; Sheep

Indexed keywords

ANIMALS; DEFECTS; RATING; SCAFFOLDS (BIOLOGY); TARGETED DRUG DELIVERY; TISSUE REGENERATION;

ANIMAL MODEL; BONE REGENERATION; CRITICAL SIZE DEFECT; LOAD BEARING; NON-UNION; SHEEP;

CONTROLLED DRUG DELIVERY;

BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN; PARATHYROID HORMONE; PLATELET DERIVED GROWTH FACTOR; POLYMER; SOMATOMEDIN; VASCULOTROPIN; SIGNAL PEPTIDE;

BIOMECHANICS; BONE INFECTION; BONE NECROSIS; BONE PLATE; BONE REGENERATION; CELL THERAPY; COMORBIDITY; DRUG DELIVERY SYSTEM; ESOPHAGUS DISEASE; EXPERIMENTAL ANIMAL; FRACTURE; FRACTURE EXTERNAL FIXATION; FRACTURE NONUNION; GENE DELIVERY SYSTEM; HUMAN; INFLAMMATION; INTRAMEDULLARY NAIL; KIRSCHNER WIRE; MECHANICAL STRESS; NONHUMAN; OSTEOPOROSIS; OSTEOSYNTHESIS; PAGET BONE DISEASE; PIG; PRIORITY JOURNAL; RABBIT; REVIEW; SHEEP; TISSUE ENGINEERING; TISSUE SCAFFOLD; WEIGHT BEARING; ZEBRA FISH; ANIMAL; DISEASE MODEL; DRUG EFFECTS; MESENCHYMAL STROMA CELL; PRECLINICAL STUDY; PROCEDURES;

ANIMALS; BONE REGENERATION; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STROMAL CELLS; TISSUE SCAFFOLDS;

EID: 84947618825     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2015.07.006     Document Type: Review

References (274)

1. Mankin H.J., Hornicek F.J., Raskin K.A. Infection in massive bone allografts. Clin. Orthop. Relat. Res. 2005, 210-216.
2. Schwartz C.E., Martha J.F., Kowalski P., Wang D.A., Bode R., Li L., Kim D.H. Prospective evaluation of chronic pain associated with posterior autologous iliac crest bone graft harvest and its effect on postoperative outcome. Health Qual. Life Outcomes 2009, 7:49.
3. Sorger J.I., Hornicek F.J., Zavatta M., Menzner J.P., Gebhardt M.C., Tomford W.W., Mankin H.J. Allograft fractures revisited. Clin. Orthop. Relat. Res. 2001, 66-74.
4. Dinopoulos H., Dimitriou R., Giannoudis P.V. Bone graft substitutes: What are the options?. Surgeon 2012, 10:230-239.
5. Stafford P.R., Norris B.L. Reamer-irrigator-aspirator bone graft and bi Masquelet technique for segmental bone defect nonunions: a review of 25 cases. Injury 2011, 41:S72-S77.
6. Paley D., Maar D.C. Ilizarov bone transport treatment for tibial defects. J. Orthop. Trauma 2000, 14:76-85.
7. Dendrinos G.K., Kontos S., Lyritsis E. Use of the Ilizarov technique for treatment of non-union of the tibia associated with infection. J. Bone Joint Surg. Am. 1995, 77:835-846.
8. Pelissier P., Casoli V., Demiri E., Martin D., Baudet J. Soleus-fibula free transfer in lower limb reconstruction. Plast. Reconstr. Surg. 2000, 105:567-573.
9. Schmidmaier G., Schwabe P., Strobel C., Wildemann B. Carrier systems and application of growth factors in orthopaedics. Injury 2008, 39(Suppl. 2):S37-S43.
10. Canale S.T., Beaty J.H. Campbell's operative orthopaedics 2008, Mosby/Elsevier, Philadelphia.
11. Stannard J.P., Schenck R.J. Knee dislocations and ligamentous injuries. Surgical treatment of orthopaedic trauma 2007, Thieme Medical Publisher, New York. J.P. Stannard, A.H. Schmidt, P.J. Kregor (Eds.).
12. Miranda M.A., Moon M.S. Treatment strategy for nonunions and malunions. Surgical treatment of orthopaedic trauma 2007, 77-100. Thieme Medical Publisher, New York. J.P. Stannard, A.H. Schmidt, P.J. Kregor (Eds.).
13. Dahabreh Z., Dimitriou R., Giannoudis P.V. Health economics: a cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7. Injury 2007, 38:371-377.
14. Heckman J.D., Sarasohn-Kahn J. The economics of treating tibia fractures. The cost of delayed unions. Bulletin 1997, 56:63-72.
15. Garrison K.R., Donell S., Ryder J., Shemilt I., Mugford M., Harvey I., Song F. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. Health Technol. Assess. 2007, 11:1-150. (iii-iv).
16. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. 2012, 62:10-29.
17. Roodman G.D. Mechanisms of bone metastasis. N. Engl. J. Med. 2004, 350:1655-1664.
18. Gitelis S., Wilkins R.M., Yasko A.W. BMPs and cancer: Is the risk real? 2008, 1-4. AAOS Now.
19. Chehade M., Bachorski A. Development of the Australian Core Competencies in Musculoskeletal Basic and Clinical Science project - phase 1. Med J Aust. 2008, 189:162-165.
20. Rodriguez-Merchan E.C., Forriol F. Nonunion: general principles and experimental data. Clin. Orthop. Relat. Res. 2004, 4-12.
21. Meijer G.J., de Bruijn J.D., Koole R., van Blitterswijk C.A. Cell based bone tissue engineering in jaw defects. Biomaterials 2008, 29:3053-3061.
22. Wolff J. The classic: On the significance of the architecture of the spongy substance for the question of bone growth: a preliminary publication. 1869. Clin. Orthop. Relat. Res. 2011, 469:3077-3078.
23. Lanyon L.E. Experimental support for the trajectorial theory of bone structure. J. Bone Joint Surg. 1974, 56:160-166.
24. Lanyon L.E., Baggott D.G. Mechanical function as an influence on the structure and form of bone. J. Bone Joint Surg. 1976, 58-B:436-443.
25. Woo S.L., Kuei S.C., Amiel D., Gomez M.A., Hayes W.C., White F.C., Akeson W.H. The effect of prolonged physical training on the properties of long bone: a study of Wolff's Law. J. Bone Joint Surg. Am. 1981, 63:780-787.
26. Ehrlich P.J., Lanyon L.E. Mechanical strain and bone cell function: a review. Osteoporos. Int. 2002, 13:688-700.
27. Cierny G., III H.S.Byrd, Jones R.E. Primary versus delayed soft tissue coverage for severe open tibial fractures. A comparison of results. Clin. Orthop. Relat. Res. 1983, 54-63.
28. Schmidhammer R., Zandieh S., Mittermayr R., Pelinka L.E., Leixnering M., Hopf R., Kroepfl A., Redl H. Assessment of bone union/nonunion in an experimental model using microcomputed technology. J. Trauma 2006, 61:199-205.
29. Sharir A., Stern T., Rot C., Shahar R., Zelzer E. Muscle force regulates bone shaping for optimal load-bearing capacity during embryogenesis. Development 2011, 138:3247-3259.
30. Yang P.F., Kriechbaumer A., Albracht K., Sanno M., Ganse B., Koy T., Shang P., Bruggemann G.P., Muller L.P., Rittweger J. On the relationship between tibia torsional deformation and regional muscle contractions in habitual human exercises in vivo. J. Biomech. 2015, 48:456-464.
31. Frost H.M. Bone's mechanostat: a 2003 update. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 2003, 275:1081-1101.
32. Reilly D.T., Burstein A.H., Frankel V.H. The elastic modulus for bone. J. Biomech. 1974, 7:271-275.
33. Lotz J.C., Gerhart T.N., Hayes W.C. Mechanical properties of metaphyseal bone in the proximal femur. J. Biomech. 1991, 24:317-329.
34. Autefage A., Palierne S., Charron C., Swider P. Effective mechanical properties of diaphyseal cortical bone in the canine femur. Vet. J. 1997, 194(2012):202-209.
35. Ayers R.A., Miller M.R., Simske S.J., Norrdin R.W. Correlation of flexural structural properties with bone physical properties: a four species survey. Biomed. Sci. Instrum. 1996, 32:251-260.
36. Bayraktar H.H., Morgan E.F., Niebur G.L., Morris G.E., Wong E.K., Keaveny T.M. Comparison of the elastic and yield properties of human femoral trabecular and cortical bone tissue. J. Biomech. 2004, 37:27-35.
37. Burstein A.H., Reilly D.T., Martens M. Aging of bone tissue: mechanical properties. J. Bone Joint Surg. Am. 1976, 58:82-86.
38. McCalden R.W., McGeough J.A., Barker M.B., Court-Brown C.M. Age-related changes in the tensile properties of cortical bone. The relative importance of changes in porosity, mineralization, and microstructure. J. Bone Joint Surg. Am. 1993, 75:1193-1205.
39. Hak D.J., Fitzpatrick D., Bishop J.A., Marsh J.L., Tilp S., Schnettler R., Simpson H., Alt V. Delayed union and nonunions: epidemiology, clinical issues, and financial aspects. Injury 2014, 45(Suppl. 2):S3-S7.
40. Paley D., Catagni M.A., Argnani F., Villa A., Benedetti G.B., Cattaneo R. Ilizarov treatment of tibial nonunions with bone loss. Clin. Orthop. Relat. Res. 1989, 146-165.
41. Weber B.G., C.O. Pseudarthrosis, grune and statton 1976, New York.
42. Reed A.A., Joyner C.J., Brownlow H.C., Simpson A.H. Human atrophic fracture non-unions are not avascular. J. Orthop. Res. 2002, 20:593-599.
43. Calori G.M., Phillips M., Jeetle S., Tagliabue L., Giannoudis P.V. Classification of non-union: need for a new scoring system?. Injury 2008, 39(Suppl. 2):S59-S63.
44. Cierny G., III K.E.Zorn Segmental tibial defects. Comparing conventional and Ilizarov methodologies. Clin. Orthop. Relat. Res. 1994, 118-123.
45. Younger E.M., Chapman M.W. Morbidity at bone graft donor sites. J. Orthop. Trauma 1989, 3:192-195.
46. Craig J., Fuchs T., Jenks M., Fleetwood K., Franz D., Iff J., Raschke M. Systematic review and meta-analysis of the additional benefit of local prophylactic antibiotic therapy for infection rates in open tibia fractures treated with intramedullary nailing. Int. Orthop. 2014, 38:1025-1030.
47. Kaplan S.L. Recent lessons for the management of bone and joint infections. J. Infect. 2014, 68(Suppl. 1):S51-S56.
48. Rachner T.D., Khosla S., Hofbauer L.C. Osteoporosis: now and the future. Lancet 2011, 377:1276-1287.
49. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
50. I.D.Federation Diabetes Atlas 2003 2003.
51. Salerno M., Argenziano A., Di Maio S., Gasparini N., Formicola S., De Filippo G., Tenore A. Pubertal growth, sexual maturation, and final height in children with IDDM. Effects of age at onset and metabolic control. Diabetes Care 1997, 20:721-724.
52. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos. Int. 2007, 18:427-444.
53. Schwartz A.V. Diabetes mellitus: Does it affect bone?. Calcif. Tissue Int. 2003, 73:515-519.
54. Schwartz A.V., Sellmeyer D.E., Ensrud K.E., Cauley J.A., Tabor H.K., Schreiner P.J., Jamal S.A., Black D.M., Cummings S.R. Older women with diabetes have an increased risk of fracture: a prospective study. J. Clin. Endocrinol. Metab. 2001, 86:32-38.
55. Forsen L., Meyer H.E., Midthjell K., Edna T.H. Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia 1999, 42:920-925.
56. Nicodemus K.K., Folsom A.R. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001, 24:1192-1197.
57. Ivers R.Q., Cumming R.G., Mitchell P., Peduto A.J. Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care 2001, 24:1198-1203.
58. Ottenbacher K.J., Ostir G.V., Peek M.K., Goodwin J.S., Markides K.S. Diabetes mellitus as a risk factor for hip fracture in mexican american older adults. J. Gerontol. A Biol. Sci. Med. Sci. 2002, 57:M648-M653.
59. Strotmeyer E.S., Cauley J.A., Schwartz A.V., Nevitt M.C., Resnick H.E., Bauer D.C., Tylavsky F.A., de Rekeneire N., Harris T.B., Newman A.B. Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch. Intern. Med. 2005, 165:1612-1617.
60. de L., van der Klift M., de Laet C.E., van Daele P.L., Hofman A., Pols H.A. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos. Int. 2005, 16:1713-1720.
61. Janghorbani M., Feskanich D., Willett W.C., Hu F. Prospective study of diabetes and risk of hip fracture: the Nurses' Health Study. Diabetes Care 2006, 29:1573-1578.
62. Bonds D.E., Larson J.C., Schwartz A.V., Strotmeyer E.S., Robbins J., Rodriguez B.L., Johnson K.C., Margolis K.L. Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. J. Clin. Endocrinol. Metab. 2006, 91:3404-3410.
63. Vestergaard P., Rejnmark L., Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 2005, 48:1292-1299.
64. Cozen L. Does diabetes delay fracture healing?. Clin. Orthop. Relat. Res. 1972, 82:134-140.
65. Loder R.T. The influence of diabetes mellitus on the healing of closed fractures. Clin. Orthop. Relat. Res. 1988, 210-216.
66. Retzepi M., Donos N. The effect of diabetes mellitus on osseous healing. Clin. Oral Implants Res. 2010, 21:673-681.
67. Bibbo C., Lin S.S., Beam H.A., Behrens F.F. Complications of ankle fractures in diabetic patients. Orthop. Clin. North Am. 2001, 32:113-133.
68. Samorezov J.E., Alsberg E. Spatial regulation of controlled bioactive factor delivery for bone tissue engineering. Adv. Drug Deliv. Rev. 2015, 84:45-67.
69. Balmayor E.R., van Griensven M. Gene therapy for bone engineering. Front. Bioeng. Biotechnol. 2015, 3:9.
70. Drake M.T., Clarke B.L., Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin. Proc. 2008, 83:1032-1045.
71. Morris C.D., Einhorn T.A. Bisphosphonates in orthopaedic surgery. J. Bone Joint Surg. Am. 2005, 87:1609-1618.
72. Dawson J.I., Kanczler J., Tare R., Kassem M., Oreffo R.O. Concise review: bridging the gap: bone regeneration using skeletal stem cell-based strategies - where are we now?. Stem Cells 2014, 32:35-44.
73. Homma Y., Zimmermann G., Hernigou P. Cellular therapies for the treatment of non-union: the past, present and future. Injury 2013, 44(Suppl. 1):S46-S49.
74. Bueno E.M., Glowacki J. Cell-free and cell-based approaches for bone regeneration. Nat. Rev. Rheumatol. 2009, 5:685-697.
75. Wang E.A., Rosen V., D'Alessandro J.S., Bauduy M., Cordes P., Harada T., Israel D.I., Hewick R.M., Kerns K.M., LaPan P., et al. Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:2220-2224.
76. Yoshida K., Bessho K., Fujimura K., Kusumoto K., Ogawa Y., Tani Y., Iizuka T. Osteoinduction capability of recombinant human bone morphogenetic protein-2 in intramuscular and subcutaneous sites: an experimental study. J. Craniomaxillofac Surg. 1998, 26:112-115.
77. Okubo Y., Bessho K., Fujimura K., Konishi Y., Kusumoto K., Ogawa Y., Iizuka T. Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites. Int. J. Oral Maxillofac. Surg. 2000, 29:62-66.
78. Deutsch H. High-dose bone morphogenetic protein-induced ectopic abdomen bone growth. Spine J. 2010, 10:e1-e4.
79. Boraiah S., Paul O., Hawkes D., Wickham M., Lorich D.G. Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: a preliminary report. Clin. Orthop. Relat. Res. 2009, 467:3257-3262.
80. Brower R.S., Vickroy N.M. A case of psoas ossification from the use of BMP-2 for posterolateral fusion at L4-L5. Spine 2008, 33:E653-E655.
81. Zapf J., Hauri C., Waldvogel M., Froesch E.R. Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. J. Clin. Invest. 1986, 77:1768-1775.
82. Zioncheck T.F., Chen S.A., Richardson L., Mora-Worms M., Lucas C., Lewis D., Green J.D., Mordenti J. Pharmacokinetics and tissue distribution of recombinant human transforming growth factor beta 1 after topical and intravenous administration in male rats. Pharm. Res. 1994, 11:213-220.
83. Stenzel K.H., Miyata T., Rubin A.L. Collagen as a biomaterial. Annu. Rev. Biophys. Bioeng. 1974, 3:231-253.
84. Altman G.H., Diaz F., Jakuba C., Calabro T., Horan R.L., Chen J., Lu H., Richmond J., Kaplan D.L. Silk-based biomaterials. Biomaterials 2003, 24:401-416.
85. Teuschl A.H., van Griensven M., Redl H. Sericin removal from raw Bombyx mori silk scaffolds of high hierarchical order. Tissue Eng. Part C Methods 2014, 20:431-439.
86. Menard M., Dusseault J., Langlois G., Baille W.E., Tam S.K., Yahia L., Zhu X.X., Halle J.P. Role of protein contaminants in the immunogenicity of alginates. J. Biomed. Mater. Res. B Appl. Biomater. 2010, 93:333-340.
87. Nandi S.K., Kundu B., Mukherjee J., Mahato A., Datta S., Balla V.K. Converted marine coral hydroxyapatite implants with growth factors: In vivo bone regeneration. Mater. Sci. Eng., C 2015, 49:816-823.
88. Kattimani V.S., Chakravarthi P.S., Kanumuru N.R., Subbarao V.V., Sidharthan A., Kumar T.S., Prasad L.K. Eggshell derived hydroxyapatite as bone graft substitute in the healing of maxillary cystic bone defects: a preliminary report. J. Int. Oral Health 2014, 6:15-19.
89. Zhou A.J., Clokie C.M., Peel S.A. Bone formation in algae-derived and synthetic calcium phosphates with or without poloxamer. J. Craniofac. Surg. 2013, 24:354-359.
90. Wang L., Barbieri D., Zhou H., de Bruijn J.D., Bao C., Yuan H. Effect of particle size on osteoinductive potential of microstructured biphasic calcium phosphate ceramic. J. Biomed. Mater. Res. A 2015, 103:1919-1929.
91. Zhang J., Barbieri D., ten Hoopen H., de Bruijn J.D., van Blitterswijk C.A., Yuan H. Microporous calcium phosphate ceramics driving osteogenesis through surface architecture. J. Biomed. Mater. Res. A 2015, 103:1188-1199.
92. Zhang J., Luo X., Barbieri D., Barradas A.M., de Bruijn J.D., van Blitterswijk C.A., Yuan H. The size of surface microstructures as an osteogenic factor in calcium phosphate ceramics. Acta Biomater. 2014, 10:3254-3263.
93. Tamada J.A., Langer R. Erosion kinetics of hydrolytically degradable polymers. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:552-556.
94. Luginbuehl V., Meinel L., Merkle H.P., Gander B. Localized delivery of growth factors for bone repair. Eur. J. Pharm. Biopharm. 2004, 58:197-208.
95. Horrobin D.F. Modern biomedical research: an internally self-consistent universe with little contact with medical reality?. Nat. Rev. Drug Discov. 2003, 2:151-154.
96. Egermann M., Goldhahn J., Schneider E. Animal models for fracture treatment in osteoporosis. Osteoporos. Int. 2005, 16(Suppl. 2):S129-S138.
97. Liebschner M.A. Biomechanical considerations of animal models used in tissue engineering of bone. Biomaterials 2004, 25:1697-1714.
98. Reichert J.C., Saifzadeh S., Wullschleger M.E., Epari D.R., Schutz M.A., Duda G.N., Schell H., van Griensven M., Redl H., Hutmacher D.W. The challenge of establishing preclinical models for segmental bone defect research. Biomaterials 2009, 30:2149-2163.
99. Keibl C., Fugl A., Zanoni G., Tangl S., Wolbank S., Redl H., van Griensven M. Human adipose derived stem cells reduce callus volume upon BMP-2 administration in bone regeneration. Injury 2011, 42:814-820.
100. Castellani C., Zanoni G., Tangl S., van Griensven M., Redl H. Biphasic calcium phosphate ceramics in small bone defects: potential influence of carrier substances and bone marrow on bone regeneration. Clin. Oral Implants Res. 2009, 20:1367-1374.
101. Tarkka T., Sipola A., Jamsa T., Soini Y., Yla-Herttuala S., Tuukkanen J., Hautala T. Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. J. Gene Med. 2003, 5:560-566.
102. Bonnarens F., Einhorn T.A. Production of a standard closed fracture in laboratory animal bone. J. Orthop. Res. 1984, 2:97-101.
103. Nunamaker D.M. Experimental models of fracture repair. Clin. Orthop. Relat. Res. 1998, S56-S65.
104. Park S.H., O'Connor K., Sung R., McKellop H., Sarmiento A. Comparison of healing process in open osteotomy model and closed fracture model. J. Orthop. Trauma 1999, 13:114-120.
105. Kaipel M., Schutzenberger S., Schultz A., Ferguson J., Slezak P., Morton T.J., Van Griensven M., Redl H. BMP-2 but not VEGF or PDGF in fibrin matrix supports bone healing in a delayed-union rat model. J. Orthop. Res. 2012, 30:1563-1569.
106. Heckman J.D., Ehler W., Brooks B.P., Aufdemorte T.B., Lohmann C.H., Morgan T., Boyan B.D. Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer. J. Bone Joint Surg. Am. 1999, 81:1717-1729.
107. Cook S.D., Baffes G.C., Wolfe M.W., Sampath T.K., Rueger D.C., Whitecloud T.S. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J. Bone Joint Surg. Am. 1994, 76:827-838.
108. Key J.A. The effect of a local calcium depot on osteogenesis and healing of fractures. J. Bone Joint Surg. Am. 1934, 16:176-184.
109. Chao E.Y., Inoue N., Koo T.K., Kim Y.H. Biomechanical considerations of fracture treatment and bone quality maintenance in elderly patients and patients with osteoporosis. Clin. Orthop. Relat. Res. 2004, 12-25.
110. Chao E.Y., Aro H.T., Lewallen D.G., Kelly P.J. The effect of rigidity on fracture healing in external fixation. Clin. Orthop. Relat. Res. 1989, 24-35.
111. Augat P., Merk J., Ignatius A., Margevicius K., Bauer G., Rosenbaum D., Claes L. Early, full weightbearing with flexible fixation delays fracture healing. Clin. Orthop. Relat. Res. 1996, 194-202.
112. Claes L. The mechanical and morphological properties of bone beneath internal fixation plates of differing rigidity. J. Orthop. Res. 1989, 7:170-177.
113. Horner E.A., Kirkham J., Wood D., Curran S., Smith M., Thomson B., Yang X.B. Long bone defect models for tissue engineering applications: criteria for choice. Tissue Eng. B Rev. 2010, 16:263-271.
114. Barros T.P., Alderton W.K., Reynolds H.M., Roach A.G., Berghmans S. Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery. Br. J. Pharmacol. 2008, 154:1400-1413.
115. Goldsmith P. Zebrafish as a pharmacological tool: the how, why and when. Curr. Opin. Pharmacol. 2004, 4:504-512.
116. Parng C. In vivo zebrafish assays for toxicity testing. Curr. Opin. Drug Discov. Devel. 2005, 8:100-106.
117. Zon L.I., Peterson R.T. In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 2005, 4:35-44.
118. Rubinstein A.L. Zebrafish assays for drug toxicity screening. Expert Opin. Drug Metab. Toxicol. 2006, 2:231-240.
119. Rombough P. Gills are needed for ionoregulation before they are needed for O(2) uptake in developing zebrafish, Danio rerio. J. Exp. Biol. 2002, 205:1787-1794.
120. Spaink H.P., Cui C., Wiweger M.I., Jansen H.J., Veneman W.J., Marin-Juez R., de Sonneville J., Ordas A., Torraca V., van der Ent W., Leenders W.P., Meijer A.H., Snaar-Jagalska B.E., Dirks R.P. Robotic injection of zebrafish embryos for high-throughput screening in disease models. Methods 2013, 62:246-254.
121. Deo R.C., MacRae C.A. The zebrafish: scalable in vivo modeling for systems biology. Wiley Interdiscip. Rev. Syst. Biol. Med. 2011, 3:335-346.
122. Mari-Beffa M., Santamaria J.A., Murciano C., Santos-Ruiz L., Andrades J.A., Guerado E., Becerra J. Zebrafish fins as a model system for skeletal human studies. TheScientificWorldJOURNAL 2007, 7:1114-1127.
123. Schilling T.F., Kimmel C.B. Segment and cell type lineage restrictions during pharyngeal arch development in the zebrafish embryo. Development 1994, 120:483-494.
124. Cubbage C.C., Mabee P.M. Development of the cranium and paired fins in the zebrafish Danio rerio (Ostariophysi, Cyprinidae). J. Morphol. 1996, 229:121-160.
125. Fleming A., Keynes R., Tannahill D. A central role for the notochord in vertebral patterning. Development 2004, 131:873-880.
126. Inohaya K., Takano Y., Kudo A. The teleost intervertebral region acts as a growth center of the centrum: in vivo visualization of osteoblasts and their progenitors in transgenic fish. Dev. Dyn. 2007, 236:3031-3046.
127. Pasqualetti S., Banfi G., Mariotti M. The zebrafish scale as model to study the bone mineralization process. J. Mol. Histol. 2012, 43:589-595.
128. Knopf F., Hammond C., Chekuru A., Kurth T., Hans S., Weber C.W., Mahatma G., Fisher S., Brand M., Schulte-Merker S., Weidinger G. Bone regenerates via dedifferentiation of osteoblasts in the zebrafish fin. Dev. Cell 2011, 20:713-724.
129. Witten P.E., Hansen A., Hall B.K. Features of mono- and multinucleated bone resorbing cells of the zebrafish Danio rerio and their contribution to skeletal development, remodeling, and growth. J. Morphol. 2001, 250:197-207.
130. Fleming A., Sato M., Goldsmith P. High-throughput in vivo screening for bone anabolic compounds with zebrafish. J. Biomol. Screen. 2005, 10:823-831.
131. Hammond C.L., Moro E. Using transgenic reporters to visualize bone and cartilage signaling during development in vivo. Front. Endocrinol. 2012, 3:91.
132. Mueller C.W., Hildebrandt K., Gerich T., Krettek C., van Griensven M., Balmayor E.R. BMP-2 transduced human bone marrow stem cells enhanced neo-bone formation in a rat critical size femur defect. J. Tissue Eng. Regen. Med. 2015.
133. Schliephake H., Zghoul N., Jager V., van Griensven M., Zeichen J., Gelinsky M., Szubtarsky N. Bone formation in trabecular bone cell seeded scaffolds used for reconstruction of the rat mandible. Int. J. Oral Maxillofac. Surg. 2009, 38:166-172.
134. Peterson B., Zhang J., Iglesias R., Kabo M., Hedrick M., Benhaim P., Lieberman J.R. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng. 2005, 11:120-129.
135. Einhorn T.A. The cell and molecular biology of fracture healing. Clin. Orthop. Relat. Res. 1998, S7-S21.
136. Zoetis T., Tassinari M.S., Bagi C., Walthall K., Hurtt M.E. Species comparison of postnatal bone growth and development. Birth Defects Res. B Dev. Reprod. Toxicol. 2003, 68:86-110.
137. Jepsen K.J., Pennington D.E., Lee Y.L., Warman M., Nadeau J. Bone brittleness varies with genetic background in A/J and C57BL/6J inbred mice. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2001, 16:1854-1862.
138. Bi X., Patil C.A., Lynch C.C., Pharr G.M., Mahadevan-Jansen A., Nyman J.S. Raman and mechanical properties correlate at whole bone- and tissue-levels in a genetic mouse model. J. Biomech. 2011, 44:297-303.
139. Courtland H.W., Nasser P., Goldstone A.B., Spevak L., Boskey A.L., Jepsen K.J. Fourier transform infrared imaging microspectroscopy and tissue-level mechanical testing reveal intraspecies variation in mouse bone mineral and matrix composition. Calcif. Tissue Int. 2008, 83:342-353.
140. Voide R., van Lenthe G.H., Muller R. Differential effects of bone structural and material properties on bone competence in C57BL/6 and C3H/He inbred strains of mice. Calcif. Tissue Int. 2008, 83:61-69.
141. Wang X., Mabrey J.D., Agrawal C.M. An interspecies comparison of bone fracture properties. Bio-Med. Mater. Eng. 1998, 8:1-9.
142. Bagi C.M., DeLeon E., Ammann P., Rizzoli R., Miller S.C. Histo-anatomy of the proximal femur in rats: impact of ovariectomy on bone mass, structure, and stiffness. Anat. Rec. 1996, 245:633-644.
143. Takato T., Harii K., Nakatsuka T. Osteogenic capacity of vascularised periosteum: experimental study using rib periosteum in rabbits. Br. J. Plast. Surg. 1988, 41:528-532.
144. Yachouh J., Breton P., Roux J.P., Goudot P. Osteogenic capacity of vascularised periosteum: an experimental study on mandibular irradiated bone in rabbits. J. Plast. Reconstr. Aesthet. Surg. 2010, 63:2160-2167.
145. Chen A.C., Lin S.S., Chan Y.S., Lee M.S., Ueng S.W. Osteogenesis of prefabricated vascularized periosteal graft in rabbits. J. Trauma 2009, 67:165-167.
146. Kokubu T., Hak D.J., Hazelwood S.J., Reddi A.H. Development of an atrophic nonunion model and comparison to a closed healing fracture in rat femur. J. Orthop. Res. 2003, 21:503-510.
147. Bostrom M., Lane J.M., Tomin E., Browne M., Berberian W., Turek T., Smith J., Wozney J., Schildhauer T. Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin. Orthop. Relat. Res. 1996, 272-282.
148. Kim J., Breur G.J. Temporospatial and kinetic characteristics of sheep walking on a pressure sensing walkway. Can. J. Vet. Res. 2008, 72:50-55.
149. Cavagna G.A., Heglund N.C., Taylor C.R. Mechanical work in terrestrial locomotion: two basic mechanisms for minimizing energy expenditure. Am. J. Physiol. 1977, 233:R243-R261.
150. Newman E., Turner A.S., Wark J.D. The potential of sheep for the study of osteopenia: current status and comparison with other animal models. Bone 1995, 16:277S-284S.
151. Swindle M.M., Smith A.C., Hepburn B.J. Swine as models in experimental surgery. J. Invest. Surg. 1988, 1:65-79.
152. Nafei A., Danielsen C.C., Linde F., Hvid I. Properties of growing trabecular ovine bone. Part I: mechanical and physical properties. J. Bone Joint Surg. 2000, 82:910-920.
153. Ravaglioli A., Krajewski A., Celotti G.C., Piancastelli A., Bacchini B., Montanari L., Zama G., Piombi L. Mineral evolution of bone. Biomaterials 1996, 17:617-622.
154. Willie B.M., Bloebaum R.D., Bireley W.R., Bachus K.N., Hofmann A.A. Determining relevance of a weight-bearing ovine model for bone ingrowth assessment. J. Biomed. Mater. Res. A 2004, 69:567-576.
155. Turner A.S., Alvis M., Myers W., Stevens M.L., Lundy M.W. Changes in bone mineral density and bone-specific alkaline phosphatase in ovariectomized ewes. Bone 1995, 17:395S-402S.
156. Chavassieux P., Pastoureau P., Boivin G., Chapuy M.C., Delmas P.D., Meunier P.J. Dose effects on ewe bone remodeling of short-term sodium fluoride administration--a histomorphometric and biochemical study. Bone 1991, 12:421-427.
157. den Boer F.C., Patka P., Bakker F.C., Wippermann B.W., van Lingen A., Vink G.Q., Boshuizen K., Haarman H.J. New segmental long bone defect model in sheep: quantitative analysis of healing with dual energy x-ray absorptiometry. J. Orthop. Res. 1999, 17:654-660.
158. Knothe Tate M.L., Ritzman T.F., Schneider E., Knothe U.R. Testing of a new one-stage bone-transport surgical procedure exploiting the periosteum for the repair of long-bone defects. J. Bone Joint Surg. Am. 2007, 89:307-316.
159. Wippermann B., Donow C., Schratt H.E., den Boer F.C., Blokhuis T., Patka P. The influence of hydroxyapatite granules on the healing of a segmental defect filled with autologous bone marrow. Ann. Chir. Gynaecol. 1999, 88:194-197.
160. Cheng M.H., Brey E.M., Allori A., Satterfield W.C., Chang D.W., Patrick C.W., Miller M.J. Ovine model for engineering bone segments. Tissue Eng. 2005, 11:214-225.
161. Bloemers F.W., Blokhuis T.J., Patka P., Bakker F.C., Wippermann B.W., Haarman H.J. Autologous bone versus calcium-phosphate ceramics in treatment of experimental bone defects. J. Biomed. Mater. Res. B Appl. Biomater. 2003, 66:526-531.
162. Eitel F., Klapp F., Jacobson W., Schweiberer L. Bone regeneration in animals and in man. A contribution to understanding the relative value of animal experiments to human pathophysiology. Arch. Orthop. Trauma Surg. 1981, 99:59-64.
163. Aerssens J., Boonen S., Lowet G., Dequeker J. Interspecies differences in bone composition, density, and quality: potential implications for in vivo bone research. Endocrinology 1998, 139:663-670.
164. Mosekilde L., Weisbrode S.E., Safron J.A., Stills H.F., Jankowsky M.L., Ebert D.C., Danielsen C.C., Sogaard C.H., Franks A.F., Stevens M.L., et al. Calcium-restricted ovariectomized Sinclair S-1 minipigs: an animal model of osteopenia and trabecular plate perforation. Bone 1993, 14:379-382.
165. Mosekilde L., Kragstrup J., Richards A. Compressive strength, ash weight, and volume of vertebral trabecular bone in experimental fluorosis in pigs. Calcif. Tissue Int. 1987, 40:318-322.
166. Martinez-Gonzalez J.M., Cano-Sanchez J., Campo-Trapero J., Gonzalo-Lafuente J.C., Diaz-Reganon J., Vazquez-Pineiro M.T. Evaluation of minipigs as an animal model for alveolar distraction. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2005, 99:11-16.
167. Laiblin C., Jaeschke G. Clinical chemistry examinations of bone and muscle metabolism under stress in the Gottingen miniature pig--an experimental study. Berl. Munch. Tierarztl. Wochenschr. 1979, 92:124-128.
168. Martiniakova M., Grosskopf B., Omelka R., Vondrakova M., Bauerova M. Differences among species in compact bone tissue microstructure of mammalian skeleton: use of a discriminant function analysis for species identification. J. Forensic Sci. 2006, 51:1235-1239.
169. Pellegrini G., Seol Y.J., Gruber R., Giannobile W.V. Pre-clinical models for oral and periodontal reconstructive therapies. J. Dent. Res. 2009, 88:1065-1076.
170. Kim C.S., Um Y.J., Chai J.K., Cho K.S., Moon I.S., Choi S.H., Jung U.W., Lee D.W., Kim C.K. A canine model for histometric evaluation of periodontal regeneration. Periodontol. 2011, 2000(56):209-226.
171. Brittijn S.A., Duivesteijn S.J., Belmamoune M., Bertens L.F., Bitter W., de Bruijn J.D., Champagne D.L., Cuppen E., Flik G., Vandenbroucke-Grauls C.M., Janssen R.A., de Jong I.M., de Kloet E.R., Kros A., Meijer A.H., Metz J.R., van der Sar A.M., Schaaf M.J., Schulte-Merker S., Spaink H.P., Tak P.P., Verbeek F.J., Vervoordeldonk M.J., Vonk F.J., Witte F., Yuan H., Richardson M.K. Zebrafish development and regeneration: new tools for biomedical research. Int. J. Dev. Biol. 2009, 53:835-850.
172. de Vrieze E., Zethof J., Schulte-Merker S., Flik G., Metz J.R. Identification of novel osteogenic compounds by an ex-vivo sp7:luciferase zebrafish scale assay. Bone 2015, 74c:106-113.
173. Geurtzen K., Knopf F., Wehner D., Huitema L.F., Schulte-Merker S., Weidinger G. Mature osteoblasts dedifferentiate in response to traumatic bone injury in the zebrafish fin and skull. Development 2014, 141:2225-2234.
174. Singh S.P., Holdway J.E., Poss K.D. Regeneration of amputated zebrafish fin rays from de novo osteoblasts. Dev. Cell 2012, 22:879-886.
175. Stewart S., Gomez A.W., Armstrong B.E., Henner A., Stankunas K. Sequential and opposing activities of Wnt and BMP coordinate zebrafish bone regeneration. Cell Rep. 2014, 6:482-498.
176. Sousa S., Valerio F., Jacinto A. A new zebrafish bone crush injury model. Biol. Open 2012, 1:915-921.
177. de Vrieze E., van Kessel M.A., Peters H.M., Spanings F.A., Flik G., Metz J.R. Prednisolone induces osteoporosis-like phenotype in regenerating zebrafish scales. Osteoporos. Int. 2014, 25:567-578.
178. Scott M.A., Levi B., Askarinam A., Nguyen A., Rackohn T., Ting K., Soo C., James A.W. Brief review of models of ectopic bone formation. Stem Cells Dev. 2012, 21:655-667.
179. Urist M.R. Bone: formation by autoinduction. Science 1965, 150:893-899.
180. Tanaka M., Sakai A., Uchida S., Tanaka S., Nagashima M., Katayama T., Yamaguchi K., Nakamura T. Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats. Bone 2004, 34:940-948.
181. Demirkan N., Demirkan F., Aksoy A., Ozdemir M., Akman A. Local rhBMP-2 injection after drill-hole injury in rats: does it have systemic effects?. Int. J. Immunopathol. Pharmacol. 2014, 27:253-260.
182. An Y., Friedman R.J., Parent T., Draughn R.A. Production of a standard closed fracture in the rat tibia. J. Orthop. Trauma 1994, 8:111-115.
183. Glatt V., Evans C.H., Matthys R. Design, characterisation and in vivo testing of a new, adjustable stiffness, external fixator for the rat femur. Eur. Cell. Mater. 2012, 23:289-298. (discussion 299).
184. Spicer P.P., Kretlow J.D., Young S., Jansen J.A., Kasper F.K., Mikos A.G. Evaluation of bone regeneration using the rat critical size calvarial defect. Nat. Protoc. 2012, 7:1918-1929.
185. Shah N.J., Hyder M.N., Quadir M.A., Dorval Courchesne N.M., Seeherman H.J., Nevins M., Spector M., Hammond P.T. Adaptive growth factor delivery from a polyelectrolyte coating promotes synergistic bone tissue repair and reconstruction. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:12847-12852.
186. Kimoto T., Hosokawa R., Kubo T., Maeda M., Sano A., Akagawa Y. Continuous administration of basic fibroblast growth factor (FGF-2) accelerates bone induction on rat calvaria--an application of a new drug delivery system. J. Dent. Res. 1998, 77:1965-1969.
187. Nair M.B., Kretlow J.D., Mikos A.G., Kasper F.K. Infection and tissue engineering in segmental bone defects--a mini review. Curr. Opin. Biotechnol. 2011, 22:721-725.
188. Schmidmaier G., Lucke M., Wildemann B., Haas N.P., Raschke M. Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Injury 2006, 37(Suppl. 2):S105-S112.
189. Lucke M., Wildemann B., Sadoni S., Surke C., Schiller R., Stemberger A., Raschke M., Haas N.P., Schmidmaier G. Systemic versus local application of gentamicin in prophylaxis of implant-related osteomyelitis in a rat model. Bone 2005, 36:770-778.
190. Lucke M., Schmidmaier G., Sadoni S., Wildemann B., Schiller R., Haas N.P., Raschke M. Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone 2003, 32:521-531.
191. Wilson G.L., Leiter E.H. Streptozotocin interactions with pancreatic beta cells and the induction of insulin-dependent diabetes. Curr. Top. Microbiol. Immunol. 1990, 156:27-54.
192. Fontaine J.L., Hunt N.A., Curry S., Kearney T., Jupiter D., Shibuya N., Lavery L.A. Fracture healing and biomarker expression in a diabetic Zucker rat model. J. Am. Podiatr. Med. Assoc. 2014, 104:428-433.
193. Liporace F.A., Breitbart E.A., Yoon R.S., Doyle E., Paglia D.N., Lin S. The effect of locally delivered recombinant human bone morphogenetic protein-2 with hydroxyapatite/tri-calcium phosphate on the biomechanical properties of bone in diabetes-related osteoporosis. J. Orthop. Traumatol. 2015, 16:151-159.
194. Xing D.G., Liu Z.H., Gao H.W., Ma W.L., Nie L., Gong M.Z. Effect of transplantation of marrow mesenchymal stem cells transfected with insulin-like growth factor-1 gene on fracture healing of rats with diabetes. Bratisl. Lek. Listy 2015, 116:64-68.
195. Hamann C., Picke A.K., Campbell G.M., Balyura M., Rauner M., Bernhardt R., Huber G., Morlock M.M., Gunther K.P., Bornstein S.R., Gluer C.C., Ludwig B., Hofbauer L.C. Effects of parathyroid hormone on bone mass, bone strength, and bone regeneration in male rats with type 2 diabetes mellitus. Endocrinology 2014, 155:1197-1206.
196. Liang L., Song Y., Li L., Li D., Qin M., Zhao J., Xie C., Sun D., Liu Y., Jiao T., Liu N., Zou G. Adipose-derived stem cells combined with inorganic bovine bone in calvarial bone healing in rats with type 2 diabetes. J. Periodontol. 2014, 85:601-609.
197. Brown N.L., Rose M.B., Blueschke G., Cho E.H., Schoenfisch M.H., Erdmann D., Klitzman B. Bioburden after Staphylococcus aureus inoculation in type 1 diabetic rats undergoing internal fixation. Plast. Reconstr. Surg. 2014, 134:412e-419e.
198. Lelovas P.P., Xanthos T.T., Thoma S.E., Lyritis G.P., Dontas I.A. The laboratory rat as an animal model for osteoporosis research. Comp. Med. 2008, 58:424-430.
199. Jee W.S., Ma Y. Animal models of immobilization osteopenia. Morphologie 1999, 83:25-34.
200. Giardino R., Fini M., Giavaresi G., Mongiorgi R., Gnudi S., Zati A. Experimental surgical model in osteoporosis study. Boll. Soc. Ital. Biol. Sper. 1993, 69:453-460.
201. Frost H.M., Jee W.S. On the rat model of human osteopenias and osteoporoses. Bone Miner. 1992, 18:227-236.
202. Kalu D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 1991, 15:175-191.
203. Liang H., Wang K., Shimer A.L., Li X., Balian G., Shen F.H. Use of a bioactive scaffold for the repair of bone defects in a novel reproducible vertebral body defect model. Bone 2010, 47:197-204.
204. Liang H., Li X., Shimer A.L., Balian G., Shen F.H. A novel strategy of spine defect repair with a degradable bioactive scaffold preloaded with adipose-derived stromal cells. Spine J. 2014, 14:445-454.
205. Sheyn D., Kallai I., Tawackoli W., Cohn Yakubovich D., Oh A., Su S., Da X., Lavi A., Kimelman-Bleich N., Zilberman Y., Li N., Bae H., Gazit Z., Pelled G., Gazit D. Gene-modified adult stem cells regenerate vertebral bone defect in a rat model. Mol. Pharm. 2011, 8:1592-1601.
206. Vanecek V., Klima K., Kohout A., Foltan R., Jirousek O., Sedy J., Stulik J., Sykova E., Jendelova P. The combination of mesenchymal stem cells and a bone scaffold in the treatment of vertebral body defects. Eur. Spine J. 2013, 22:2777-2786.
207. Gilsanz V., Roe T.F., Gibbens D.T., Schulz E.E., Carlson M.E., Gonzalez O., Boechat M.I. Effect of sex steroids on peak bone density of growing rabbits. Am. J. Physiol. 1988, 255:E416-E421.
208. Castaneda S., Largo R., Calvo E., Rodriguez-Salvanes F., Marcos M.E., Diaz-Curiel M., Herrero-Beaumont G. Bone mineral measurements of subchondral and trabecular bone in healthy and osteoporotic rabbits. Skelet. Radiol. 2006, 35:34-41.
209. El Backly R.M., Zaky S.H., Muraglia A., Tonachini L., Brun F., Canciani B., Chiapale D., Santolini F., Cancedda R., Mastrogiacomo M. A platelet-rich plasma-based membrane as a periosteal substitute with enhanced osteogenic and angiogenic properties: a new concept for bone repair. Tissue Eng. Part A 2013, 19:152-165.
210. Bax B.E., Wozney J.M., Ashhurst D.E. Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia. Calcif. Tissue Int. 1999, 65:83-89.
211. Bouxsein M.L., Turek T.J., Blake C.A., D'Augusta D., Li X., Stevens M., Seeherman H.J., Wozney J.M. Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model. J. Bone Joint Surg. Am. 2001, 83-A:1219-1230.
212. Inui K., Maeda M., Sano A., Fujioka K., Yutani Y., Sakawa A., Yamano Y., Kato Y., Koike T. Local application of basic fibroblast growth factor minipellet induces the healing of segmental bony defects in rabbits. Calcif. Tissue Int. 1998, 63:490-495.
213. Kato T., Kawaguchi H., Hanada K., Aoyama I., Hiyama Y., Nakamura T., Kuzutani K., Tamura M., Kurokawa T., Nakamura K. Single local injection of recombinant fibroblast growth factor-2 stimulates healing of segmental bone defects in rabbits. J. Orthop. Res. 1998, 16:654-659.
214. Luppen C.A., Blake C.A., Ammirati K.M., Stevens M.L., Seeherman H.J., Wozney J.M., Bouxsein M.L. Recombinant human bone morphogenetic protein-2 enhances osteotomy healing in glucocorticoid-treated rabbits. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2002, 17:301-310.
215. Kim J., McBride S., Dean D.D., Sylvia V.L., Doll B.A., Hollinger J.O. In vivo performance of combinations of autograft, demineralized bone matrix, and tricalcium phosphate in a rabbit femoral defect model. Biomed. Mater. 2014, 9:035010.
216. Oryan A., Bigham-Sadegh A., Abbasi-Teshnizi F. Effects of osteogenic medium on healing of the experimental critical bone defect in a rabbit model. Bone 2014, 63:53-60.
217. de Mello e Oliveira R., Pelegrine A.A., Aloise A.C., Ferreira L.M. Xenograft impregnated with bone marrow mononuclear fraction for appositional bone regeneration in rabbit calvaria: a clinical and histomorphometric study. Int. J. Oral Maxillofac. Implants 2014, 29:962-968.
218. Lee S.H., Lim P., Yoon H.J. The influence of cortical perforation on guided bone regeneration using synthetic bone substitutes: a study of rabbit cranial defects. Int. J. Oral Maxillofac. Implants 2014, 29:464-471.
219. Caeiro Potes J., da Costa Reis J., Capela e Silva F., Relvas C., Silvério Cabrita A., Simoes J.A. The sheep as an animal model in orthopedic research. Exp. Path Health Sci. 2008, 2:29-32.
220. Uebersax L., Apfel T., Nuss K.M., Vogt R., Kim H.Y., Meinel L., Kaplan D.L., Auer J.A., Merkle H.P., von Rechenberg B. Biocompatibility and osteoconduction of macroporous silk fibroin implants in cortical defects in sheep. Eur. J. Pharm. Biopharm. 2013, 85:107-118.
221. von Rechenberg B., Genot O.R., Nuss K., Galuppo L., Fulmer M., Jacobson E., Kronen P., Zlinszky K., Auer J.A. Evaluation of four biodegradable, injectable bone cements in an experimental drill hole model in sheep. Eur. J. Pharm. Biopharm. 2013, 85:130-138.
222. Schneider O.D., Mohn D., Fuhrer R., Klein K., Kampf K., Nuss K.M., Sidler M., Zlinszky K., von Rechenberg B., Stark W.J. Biocompatibility and bone formation of flexible, cotton wool-like PLGA/calcium phosphate nanocomposites in sheep. Open Orthop. J. 2011, 5:63-71.
223. von Doernberg M.C., von Rechenberg B., Bohner M., Grunenfelder S., van Lenthe G.H., Muller R., Gasser B., Mathys R., Baroud G., Auer J. In vivo behavior of calcium phosphate scaffolds with four different pore sizes. Biomaterials 2006, 27:5186-5198.
224. Klein K., Zamparo E., Kronen P.W., Kampf K., Makara M., Steffen T., von Rechenberg B. Bone augmentation for cancellous bone- development of a new animal model. BMC Musculoskelet. Disord. 2013, 14:200.
225. Schemitsch E.H., Kowalski M.J., Swiontkowski M.F. Soft-tissue blood flow following reamed versus unreamed locked intramedullary nailing: a fractured sheep tibia model. Ann. Plast. Surg. 1996, 36:70-75.
226. Schemitsch E.H., Kowalski M.J., Swiontkowski M.F., Senft D. Cortical bone blood flow in reamed and unreamed locked intramedullary nailing: a fractured tibia model in sheep. J. Orthop. Trauma 1994, 8:373-382.
227. Tepic S., Remiger A.R., Morikawa K., Predieri M., Perren S.M. Strength recovery in fractured sheep tibia treated with a plate or an internal fixator: an experimental study with a two-year follow-up. J. Orthop. Trauma 1997, 11:14-23.
228. Augat P., Burger J., Schorlemmer S., Henke T., Peraus M., Claes L. Shear movement at the fracture site delays healing in a diaphyseal fracture model. J. Orthop. Res. 2003, 21:1011-1017.
229. Claes L., Eckert-Hubner K., Augat P. The effect of mechanical stability on local vascularization and tissue differentiation in callus healing. J. Orthop. Res. 2002, 20:1099-1105.
230. Reina-Romo E., Gomez-Benito M.J., Dominguez J., Niemeyer F., Wehner T., Simon U., Claes L.E. Effect of the fixator stiffness on the young regenerate bone after bone transport: computational approach. J. Biomech. 2011, 44:917-923.
231. Krischak G.D., Janousek A., Wolf S., Augat P., Kinzl L., Claes L.E. Effects of one-plane and two-plane external fixation on sheep osteotomy healing and complications. Clin. Biochem. 2002, 17:470-476.
232. Reichert J.C., Epari D.R., Wullschleger M.E., Saifzadeh S., Steck R., Lienau J., Sommerville S., Dickinson I.C., Schutz M.A., Duda G.N., Hutmacher D.W. Establishment of a preclinical ovine model for tibial segmental bone defect repair by applying bone tissue engineering strategies. Tissue Eng. B Rev. 2010, 16:93-104.
233. Gautier E., Perren S.M., Cordey J. Strain distribution in plated and unplated sheep tibia an in vivo experiment. Injury 2000, 31(Suppl. 3):C37-C44.
234. Plecko M., Lagerpusch N., Pegel B., Andermatt D., Frigg R., Koch R., Sidler M., Kronen P., Klein K., Nuss K., Gedet P., Burki A., Ferguson S.J., Stoeckle U., Auer J.A., von Rechenberg B. The influence of different osteosynthesis configurations with locking compression plates (LCP) on stability and fracture healing after an oblique 45 degrees angle osteotomy. Injury 2012, 43:1041-1051.
235. Hahn J.A., Witte T.S., Arens D., Pearce A., Pearce S. Double-plating of ovine critical sized defects of the tibia: a low morbidity model enabling continuous in vivo monitoring of bone healing. BMC Musculoskelet. Disord. 2011, 12:214.
236. Gao T.J., Lindholm T.S., Kommonen B., Ragni P., Paronzini A., Lindholm T.C., Jamsa T., Jalovaara P. Enhanced healing of segmental tibial defects in sheep by a composite bone substitute composed of tricalcium phosphate cylinder, bone morphogenetic protein, and type IV collagen. J. Biomed. Mater. Res. 1996, 32:505-512.
237. Tralman G., Andrianov V., Arend A., Mannik P., Kibur R.T., Noupuu K., Uksov D., Aunapuu M. A novel combined method of osteosynthesis in treatment of tibial fractures: a comparative study on sheep with application of rod-through-plate fixator and bone plating. Anat. Histol. Embryol. 2013, 42:80-89.
238. den Boer F.C., Wippermann B.W., Blokhuis T.J., Patka P., Bakker F.C., Haarman H.J. Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein-1 or autologous bone marrow. J. Orthop. Res. 2003, 21:521-528.
239. Blokhuis T.J., Wippermann B.W., den Boer F.C., van Lingen A., Patka P., Bakker F.C., Haarman H.J. Resorbable calcium phosphate particles as a carrier material for bone marrow in an ovine segmental defect. J. Biomed. Mater. Res. 2000, 51:369-375.
240. Goyenvalle E., Aguado E., Pilet P., Daculsi G. Biofunctionality of MBCP ceramic granules (TricOs) plus fibrin sealant (Tisseel) versus MBCP ceramic granules as a filler of large periprosthetic bone defects: an investigative ovine study. J. Mater. Sci. Mater. Med. 2010, 21:1949-1958.
241. Sarkar M.R., Augat P., Shefelbine S.J., Schorlemmer S., Huber-Lang M., Claes L., Kinzl L., Ignatius A. Bone formation in a long bone defect model using a platelet-rich plasma-loaded collagen scaffold. Biomaterials 2006, 27:1817-1823.
242. Klein M.P., Rahn B.A., Frigg R., Kessler S., Perren S.M. Reaming versus non-reaming in medullary nailing: interference with cortical circulation of the canine tibia. Arch. Orthop. Trauma Surg. 1990, 109:314-316.
243. Mueller C.A., Rahn B.A. Intramedullary pressure increase and increase in cortical temperature during reaming of the femoral medullary cavity: the effect of draining the medullary contents before reaming. J. Trauma 2003, 55:495-503. (discussion 503).
244. Pape H.C., Zelle B.A., Hildebrand F., Giannoudis P.V., Krettek C., van Griensven M. Reamed femoral nailing in sheep: does irrigation and aspiration of intramedullary contents alter the systemic response?. J. Bone Joint Surg. Am. 2005, 87:2515-2522.
245. Kreipke T.C., Rivera N.C., Garrison J.G., Easley J.T., Turner A.S., Niebur G.L. Alterations in trabecular bone microarchitecture in the ovine spine and distal femur following ovariectomy. J. Biomech. 2014, 47:1918-1921.
246. Lill C.A., Gerlach U.V., Eckhardt C., Goldhahn J., Schneider E. Bone changes due to glucocorticoid application in an ovariectomized animal model for fracture treatment in osteoporosis. Osteoporos. Int. 2002, 13:407-414.
247. Egermann M., Baltzer A.W., Adamaszek S., Evans C., Robbins P., Schneider E., Lill C.A. Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. Hum. Gene Ther. 2006, 17:507-517.
248. Egermann M., Goldhahn J., Holz R., Schneider E., Lill C.A. A sheep model for fracture treatment in osteoporosis: benefits of the model versus animal welfare. Lab. Anim. 2008, 42:453-464.
249. Beil F.T., Oheim R., Barvencik F., Hissnauer T.N., Pestka J.M., Ignatius A., Rueger J.M., Schinke T., Clarke I.J., Amling M., Pogoda P. Low turnover osteoporosis in sheep induced by hypothalamic-pituitary disconnection. J. Orthop. Res. 2012, 30:1254-1262.
250. Oheim R., Beil F.T., Kohne T., Wehner T., Barvencik F., Ignatius A., Amling M., Clarke I.J., Pogoda P. Sheep model for osteoporosis: sustainability and biomechanical relevance of low turnover osteoporosis induced by hypothalamic-pituitary disconnection. J. Orthop. Res. 2013, 31:1067-1074.
251. Bindl R., Oheim R., Pogoda P., Beil F.T., Gruchenberg K., Reitmaier S., Wehner T., Calcia E., Radermacher P., Claes L., Amling M., Ignatius A. Metaphyseal fracture healing in a sheep model of low turnover osteoporosis induced by hypothalamic-pituitary disconnection (HPD). J. Orthop. Res. 2013, 31:1851-1857.
252. Oheim R., Beil F.T., Krause M., Bindl R., Ignatius A., Pogoda P. Mandibular bone loss in ewe induced by hypothalamic-pituitary disconnection. Clin. Oral Implants Res. 2014, 25:1239-1244.
253. Wilke H.J., Kettler A., Wenger K.H., Claes L.E. Anatomy of the sheep spine and its comparison to the human spine. Anat. Rec. 1997, 247:542-555.
254. Zarrinkalam M.R., Beard H., Schultz C.G., Moore R.J. Validation of the sheep as a large animal model for the study of vertebral osteoporosis. Eur. Spine J. 2009, 18:244-253.
255. Mageed M., Berner D., Julke H., Hohaus C., Brehm W., Gerlach K. Is sheep lumbar spine a suitable alternative model for human spinal researches?. Morphometrical comparison study. Lab. Anim. Res. 2013, 29:183-189.
256. Liu D., Wu Z.X., Zhang Y., Wang C.R., Xie Q.Y., Gong K., Zhang B., Quan Y., Pan X.M. Local treatment of osteoporotic sheep vertebral body with calcium sulfate for decreasing the potential fracture risk: Microstructural and biomechanical evaluations. J. Spinal Disord. Tech. 2014.
257. Verron E., Pissonnier M.L., Lesoeur J., Schnitzler V., Fellah B.H., Pascal-Moussellard H., Pilet P., Gauthier O., Bouler J.M. Vertebroplasty using bisphosphonate-loaded calcium phosphate cement in a standardized vertebral body bone defect in an osteoporotic sheep model. Acta Biomater. 2014, 10:4887-4895.
258. Zhu X., Chen X., Chen C., Wang G., Gu Y., Geng D., Mao H., Zhang Z., Yang H. Evaluation of calcium phosphate and calcium sulfate as injectable bone cements in sheep vertebrae. J. Spinal Disord. Tech. 2012, 25:333-337.
259. Zhu X.S., Zhang Z.M., Mao H.Q., Geng D.C., Zou J., Wang G.L., Zhang Z.G., Wang J.H., Chen L., Yang H.L. A novel sheep vertebral bone defect model for injectable bioactive vertebral augmentation materials. J. Mater. Sci. Mater. Med. 2011, 22:159-164.
260. Kobayashi H., Fujishiro T., Belkoff S.M., Kobayashi N., Turner A.S., Seim H.B., Zitelli J., Hawkins M., Bauer T.W. Long-term evaluation of a calcium phosphate bone cement with carboxymethyl cellulose in a vertebral defect model. J. Biomed. Mater. Res. A 2009, 88:880-888.
261. Fujishiro T., Bauer T.W., Kobayashi N., Kobayashi H., Sunwoo M.H., Seim H.B., Turner A.S. Histological evaluation of an impacted bone graft substitute composed of a combination of mineralized and demineralized allograft in a sheep vertebral bone defect. J. Biomed. Mater. Res. A 2007, 82:538-544.
262. Kobayashi N., Ong K., Villarraga M., Schwardt J., Wenz R., Togawa D., Fujishiro T., Turner A.S., Seim H.B., Bauer T.W. Histological and mechanical evaluation of self-setting calcium phosphate cements in a sheep vertebral bone void model. J. Biomed. Mater. Res. A 2007, 81:838-846.
263. Phillips F.M., Turner A.S., Seim H.B., MacLeay J., Toth C.A., Pierce A.R., Wheeler D.L. In vivo BMP-7 (OP-1) enhancement of osteoporotic vertebral bodies in an ovine model. Spine J. 2006, 6:500-506.
264. Lamghari M., Huet H., Laurent A., Berland S., Lopez E. A model for evaluating injectable bone replacements in the vertebrae of sheep: radiological and histological study. Biomaterials 1999, 20:2107-2114.
265. Jungbluth P., Hakimi A.R., Grassmann J.P., Schneppendahl J., Betsch M., Kropil P., Thelen S., Sager M., Herten M., Wild M., Windolf J., Hakimi M. The early phase influence of bone marrow concentrate on metaphyseal bone healing. Injury 2013, 44:1285-1294.
266. Lange T.A., Zerwekh J.E., Peek R.D., Mooney V., Harrison B.H. Granular tricalcium phosphate in large cancellous defects. Ann. Clin. Lab. Sci. 1986, 16:467-472.
267. Jungbluth P., Wild M., Grassmann J.P., Ar E., Sager M., Herten M., Jager M., Becker J., Windolf J., Hakimi M. Platelet-rich plasma on calcium phosphate granules promotes metaphyseal bone healing in mini-pigs. J. Orthop. Res. 2010, 28:1448-1455.
268. Hakimi M., Jungbluth P., Sager M., Betsch M., Herten M., Becker J., Windolf J., Wild M. Combined use of platelet-rich plasma and autologous bone grafts in the treatment of long bone defects in mini-pigs. Injury 2010, 41:717-723.
269. Wiltfang J., Merten H.A., Schlegel K.A., Schultze-Mosgau S., Kloss F.R., Rupprecht S., Kessler P. Degradation characteristics of alpha and beta tri-calcium-phosphate (TCP) in minipigs. J. Biomed. Mater. Res. 2002, 63:115-121.
270. Ho K.W., Gilbody J., Jameson T., Miles A.W. The effect of 4 mm bicortical drill hole defect on bone strength in a pig femur model. Arch. Orthop. Trauma Surg. 2010, 130:797-802.
271. Schubert T., Lafont S., Beaurin G., Grisay G., Behets C., Gianello P., Dufrane D. Critical size bone defect reconstruction by an autologous 3D osteogenic-like tissue derived from differentiated adipose MSCs. Biomaterials 2013, 34:4428-4438.
272. Raschke M., Kolbeck S., Bail H., Schmidmaier G., Flyvbjerg A., Lindner T., Dahne M., Roenne I.A., Haas N. Homologous growth hormone accelerates healing of segmental bone defects. Bone 2001, 29:368-373.
273. Manolagas S.C., Kronenberg H.M. Reproducibility of results in preclinical studies: a perspective from the bone field. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2014, 29:2131-2140.
274. Kilkenny C., Browne W.J., Cuthill I.C., Emerson M., Altman D.G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010, 8:e1000412.